Clinical Trials Logo

Abortion, Habitual clinical trials

View clinical trials related to Abortion, Habitual.

Filter by:

NCT ID: NCT02144064 Recruiting - Clinical trials for Recurrent Pregnancy Loss

Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin

Start date: June 23, 2019
Phase: Phase 3
Study type: Interventional

Objective To determine maternal and fetal outcomes in women with Unexplained RPL managed with aspirin or unfractionated heparin (UFH) plus aspirin during pregnancy. Design: prospective clinical controlled study. Setting: high-risk pregnancy unit- Benha university hospital. Methods: Pregnant women with unexplained recurrent miscarriage attending high-risk pregnancy unit. 200 selected patients with previous unexplained recurrent miscarriage are divided into 2 groups: group A (n = 100) receive low-dose aspirin (81 mg once daily orally) plus heparin (5000 IU) every 12 h with the first positive pregnancy test while group B (n = 100) receive no thing . Main outcome measures: Maternal outcomes included thromboembolic and haemorrhagic complications and pregnancy-induced hypertension .Prematurity, intrauterine growth restriction and neonatal death were considered as maternal and fetal complications

NCT ID: NCT02088424 Not yet recruiting - Recurrent Abortion Clinical Trials

the Insulin Resistance in Recurrent Miscarriage IN RECURRENT ABORTION

Start date: March 2014
Phase: N/A
Study type: Observational [Patient Registry]

THE INSULIN RESISTANCE IN RECURRENT ABORTION

NCT ID: NCT01976676 Completed - Recurrent Abortion Clinical Trials

Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion

Start date: April 2011
Phase: Phase 2/Phase 3
Study type: Interventional

Recent data indicates that 5 methyltetrahydrofolate (5MTHF) can reduce serum homocystein level more efficiently than folic acid. On the other hand, folic acid is currently an important part of treatment in idiopathic recurrent abortion. There is no study comparing the effectiveness of these supplements in the treatment of recurrent abortion. The aim of this study is to compare the efficiency of these two agents in the treatment of recurrent abortion. In this study, patients with idiopathic recurrent abortion, referring to Avicenna clinic will be randomly allocated into two groups of those taking either folic acid (5 mg) or 5 MTHF (5mg) from 8 weeks prior to conception until the 20th week of pregnancy. The serum level of folate, homocystein, and ongoing pregnancy will be analysed and compared in the two groups.

NCT ID: NCT01788540 Completed - Clinical trials for Abortion, Spontaneous

Intralipid for Recurrent Miscarriage

Start date: February 2013
Phase: Phase 4
Study type: Interventional

Intralipid infusion can improve the outcome in NK cells positive females with history of recurrent miscarriages undergoing IVF/ICSI cycles.

NCT ID: NCT01762098 Completed - Infertility Clinical Trials

Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization

Start date: November 2012
Phase: N/A
Study type: Observational

Chronic endometritis is a persistent inflammation of the endometrium. Chronic endometritis is asymptomatic or little symptomatic. Sometimes, patient with chronic endometritis can have genital bleeding, pelvic chronic pain, pain during sexual relations, persistent vaginal white loosing. The hysteroscopy can detect the presence or absence of chronic endometritis. Some studies showed that the endometritis could have an impact on the embryo implantation and could explain recurrent miscarriages or repeated embryo implantation failures. The goal of this study is to evaluate the frequency of the chronic endometritis in patients with recurrent miscarriages or repeated embryo implantation failures

NCT ID: NCT01718340 Withdrawn - Abortion, Habitual Clinical Trials

Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia

MetRPL
Start date: June 2012
Phase: Phase 4
Study type: Interventional

The prevalence of insulin resistance is increased in women with recurrent miscarriage compared with matched fertile controls,Insulin resistance (IR) in this syndrome is not only implicated toward early pregnancy loss (EPL) but also pathognomic for various obstetrical complications during pregnancy.An elevated free androgen index appears to be a prognostic factor for a subsequent miscarriage in women with recurrent miscarriage. There is insufficient evidence to evaluate the effect of metformin supplementation in pregnancy to prevent a miscarriage in women with recurrent miscarriage.

NCT ID: NCT01688284 Terminated - Clinical trials for Recurrent Pregnancy Losses

The Role of Uterine NK Cells and T Cell Cytokines in Recurrent Miscarriage

Start date: March 2010
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the role of uterine natural killer cell(uNK)in recurrent pregnancy losses and the correlation between the numbers of it and embryo toxicity by measuring the level of the Th2 cytokines in normal reproductive profile and in patients with Recurrent Pregnancy Losses (RPL).

NCT ID: NCT01670929 Completed - Abortion, Habitual Clinical Trials

Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage

Start date: September 2012
Phase: Phase 4
Study type: Interventional

In women with unexplained recurrent miscarriages, progesterone (400 mg pessaries, twice daily), started soon as possible at luteal phase and after a positive pregnancy test and continued to 28 weeks of gestation, compared to placebo, ).

NCT ID: NCT01644318 Active, not recruiting - Habitual Abortion Clinical Trials

CXCL9 and CXCL11 Levels in Patients With Autoimmune Thyroiditis and Habitual Abortions

Start date: n/a
Phase: N/A
Study type: Observational

The purpose of this study is to measure serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions

NCT ID: NCT01612065 Completed - Infertility Clinical Trials

Optimum Misoprostol Dose Prior to Office Hysteroscopy

Start date: June 2012
Phase: Phase 3
Study type: Interventional

Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.